Cargando…

Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse

BACKGROUND: Vaginally assisted laparoscopic sacrocolpopexy (VALS) refers to the placement of synthetic meshes through the vagina in addition to traditional laparoscopic sacrocolpopexy. In this study, we aimed to investigate the medium- to long-term efficacy and safety of VALS for treating stage III–...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Tuo, Wang, Su, Liang, Xuezao, Chen, Liquan, Wen, Yanli, Zhang, Xiaowei, Xu, Lizhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727883/
https://www.ncbi.nlm.nih.gov/pubmed/36476590
http://dx.doi.org/10.1186/s12905-022-02105-1
_version_ 1784845122588901376
author Deng, Tuo
Wang, Su
Liang, Xuezao
Chen, Liquan
Wen, Yanli
Zhang, Xiaowei
Xu, Lizhen
author_facet Deng, Tuo
Wang, Su
Liang, Xuezao
Chen, Liquan
Wen, Yanli
Zhang, Xiaowei
Xu, Lizhen
author_sort Deng, Tuo
collection PubMed
description BACKGROUND: Vaginally assisted laparoscopic sacrocolpopexy (VALS) refers to the placement of synthetic meshes through the vagina in addition to traditional laparoscopic sacrocolpopexy. In this study, we aimed to investigate the medium- to long-term efficacy and safety of VALS for treating stage III–IV pelvic organ prolapse (POP). METHODS: The study was designed as a case series at a single center. Patients with stage III–IV POP in our hospital from January 2010 to December 2018 were included. Perioperative parameters, objective and subjective outcomes, and complications were assessed. RESULTS: A total of 106 patients completed the follow-up and were included in our study. Within a median follow-up duration of 35.4 months, the objective cure ratio of VALS reached 92.45% (98/106), and the subjective success rate was 99.06% (105/106). Patients reported significant improvements in subjective symptoms. In eight patients suffering anatomic prolapse recurrence, two posterior POP cases were treated by posterior pelvic reconstruction surgery, while six anterior POP cases did not need surgical therapies. The reoperation rate was 1.89% (2/106). No intraoperative complications occurred. Three patients (2.83%) had postoperative fever, and one (0.94%) had wound infection during hospitalization. Six patients (5.66%) had mesh exposure on the vaginal wall, and de novo urinary incontinence occurred in two patients (1.89%) during the follow-up period. CONCLUSION: VALS is an effective and safe surgical method for treating severe POP. Therefore, VALS should be considered in the treatment of severe POP due to its favorable subjective and objective outcomes, relatively low rate of infection and acceptable rate of mesh exposure.
format Online
Article
Text
id pubmed-9727883
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97278832022-12-08 Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse Deng, Tuo Wang, Su Liang, Xuezao Chen, Liquan Wen, Yanli Zhang, Xiaowei Xu, Lizhen BMC Womens Health Research BACKGROUND: Vaginally assisted laparoscopic sacrocolpopexy (VALS) refers to the placement of synthetic meshes through the vagina in addition to traditional laparoscopic sacrocolpopexy. In this study, we aimed to investigate the medium- to long-term efficacy and safety of VALS for treating stage III–IV pelvic organ prolapse (POP). METHODS: The study was designed as a case series at a single center. Patients with stage III–IV POP in our hospital from January 2010 to December 2018 were included. Perioperative parameters, objective and subjective outcomes, and complications were assessed. RESULTS: A total of 106 patients completed the follow-up and were included in our study. Within a median follow-up duration of 35.4 months, the objective cure ratio of VALS reached 92.45% (98/106), and the subjective success rate was 99.06% (105/106). Patients reported significant improvements in subjective symptoms. In eight patients suffering anatomic prolapse recurrence, two posterior POP cases were treated by posterior pelvic reconstruction surgery, while six anterior POP cases did not need surgical therapies. The reoperation rate was 1.89% (2/106). No intraoperative complications occurred. Three patients (2.83%) had postoperative fever, and one (0.94%) had wound infection during hospitalization. Six patients (5.66%) had mesh exposure on the vaginal wall, and de novo urinary incontinence occurred in two patients (1.89%) during the follow-up period. CONCLUSION: VALS is an effective and safe surgical method for treating severe POP. Therefore, VALS should be considered in the treatment of severe POP due to its favorable subjective and objective outcomes, relatively low rate of infection and acceptable rate of mesh exposure. BioMed Central 2022-12-07 /pmc/articles/PMC9727883/ /pubmed/36476590 http://dx.doi.org/10.1186/s12905-022-02105-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Deng, Tuo
Wang, Su
Liang, Xuezao
Chen, Liquan
Wen, Yanli
Zhang, Xiaowei
Xu, Lizhen
Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title_full Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title_fullStr Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title_full_unstemmed Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title_short Medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage III–IV pelvic organ prolapse
title_sort medium- to long-term outcomes of vaginally assisted laparoscopic sacrocolpopexy in the treatment of stage iii–iv pelvic organ prolapse
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9727883/
https://www.ncbi.nlm.nih.gov/pubmed/36476590
http://dx.doi.org/10.1186/s12905-022-02105-1
work_keys_str_mv AT dengtuo mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT wangsu mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT liangxuezao mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT chenliquan mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT wenyanli mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT zhangxiaowei mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse
AT xulizhen mediumtolongtermoutcomesofvaginallyassistedlaparoscopicsacrocolpopexyinthetreatmentofstageiiiivpelvicorganprolapse